SCHW enters the week on a strong footing — up 5.5% over five sessions to $93.67 — yet the most pointed signal in the data sits not in price action but in the insider ledger, where founder Charles Schwab has been a consistent seller all spring.
The insider story is hard to ignore. Charles Schwab, founder and co-chairman, sold shares on at least five separate occasions between April 30 and May 19, offloading more than 300,000 shares in total at prices ranging from $91.50 to $92.40 — proceeds exceeding $22 million in that window alone. CEO Rick Wurster offered a counterpoint: he bought nearly 22,000 shares on May 28 at $84.23, a purchase of roughly $1.85 million. The CFO's June 3 sale of 6,500 shares at $87.42 was comparatively minor. Net of all insider activity over the past 90 days, the position is slightly additive at around 637,000 shares, largely because of Wurster's buy — but the founder's repeated selling at the mid-$90s level is a detail worth keeping in view as the stock approaches those same levels again.
Short positioning tells a far quieter story, and doesn't deserve to be the lead here. Short interest is just 1.3% of the free float — low by any measure. It has climbed roughly 42% over the past month in share terms, but from a very small base; the absolute level remains well below anything that would create meaningful pressure. Borrow is essentially free, and share availability is effectively unlimited, with over 1.4 billion shares available relative to a short position of barely 23 million. The put/call ratio at 1.06 is actually running below its 20-day average of 1.19 — nearly one standard deviation lighter on the defensive side — which fits neatly with the price recovery. Options traders appear less worried right now than they were a fortnight ago, when the PCR briefly touched 1.46, its 52-week peak.
The analyst community is broadly constructive, though the most recent moves are now more than a month old. Following the Q1 print in mid-May, Raymond James raised its target to $137 and Barclays moved to $127, both maintaining positive ratings. TD Cowen nudged its Buy target to $109. Piper Sandler, sitting on the sceptical side, lifted its Neutral target only marginally to $105 — still well below the current price. The mean Street target across the panel is $116, implying roughly 24% upside from Tuesday's close. Morgan Stanley cut its Overweight target twice in April (from $148 to $125), and JP Morgan moved the other way in the same period, lifting its Overweight target to $131. Bulls point to the Workplace Services segment and the Forge Global acquisition as growth levers. Bears focus on TD Ameritrade integration drag and the intensifying fight for retail brokerage market share. At a trailing P/E just above 14 and a price-to-book near 3.3, valuation is not stretched relative to the earnings momentum picture — ORTEX factor scores put 30-day EPS momentum in the 80th percentile and 90-day in the 78th.
Earnings history adds a note of caution on the near-term setup. The last quarterly print in April sent the stock down nearly 8% in a single session, with a further 11% loss over the following five days — the sharpest post-earnings drawdown visible in the recent history. The subsequent releases produced much more contained moves. Next earnings are due July 17, roughly a month out — a natural catalyst that will frame whether the current rally has fundamental support or is simply tracking a broad financial sector recovery. Peers LPLA and RJF both rose around 5% on the week, matching SCHW step for step, which suggests the move is more sector-driven than stock-specific.
The setup into July 17 is therefore less about whether Schwab is structurally well-positioned — the Street broadly thinks it is — and more about whether the founder's consistent selling at prices close to where the stock trades today reflects information the analyst consensus has not yet priced.
See the live data behind this article on ORTEX.
Open SCHW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
